Top Markets
#1 Islamic Coin Islamic Coin +154.45%
#2 PulseChain PulseChain +48.38%
#3 Ergo Ergo +30.11%
#4 RedStone RedStone +16.56%
#5 Not in Employment, Education, or Training Not in Employment, Education, or Training +10.64%
#6 SkyAI SkyAI +10.52%
#7 Siren Siren +8.99%
#8 Lighter Lighter +8.81%
#9 Monad Monad +8.67%
#10 OPENLOOT OPENLOOT +8.16%
Coin of the day
Islamic Coin Islamic Coin
Tetapan
Bahasa
MALAY
Mata wang
USD
Tema
Lukas Biomedical Inc. Lukas Biomedical Inc.

Lukas Biomedical Inc.

6814
Kedudukan dalam Saham #27929
Founded in 2002 and headquartered in New Taipei, Taiwan, Lukas Biomedical Inc.... Founded in 2002 and headquartered in New Taipei, Taiwan, Lukas Biomedical Inc. primarily develops immune cell medical technologies. These innovations are utilized for regenerative medicine and as complementary treatments for cancer. The company's operations are segmented into four distinct areas: E-commerce, Medical Management Business, Cell Product, and Pharmaceutical Market. Furthermore, it diversifies its business by wholesaling and retailing cosmetics, alongside providing housing equipment rental services.
Harga Saham
$0.70911832
Modal Pasaran
$29.69M
Perubahan (1 hari)
0.45%
Perubahan (1 tahun)
-9.36%
Negara
TW
Perdagangan Lukas Biomedical Inc. (6814)

Kategori

Healthcare
Hasil untuk Lukas Biomedical Inc. (6814)
Hasil pada Aug 2026 TTM: 0
Menurut laporan kewangan terkini daripada Lukas Biomedical Inc., hasil semasa syarikat (TTM) ialah 0. Pada tahun 2026, syarikat memperoleh hasil sebanyak 0 sama dengan hasil pada tahun 2026 iaitu 0. Hasil ialah jumlah pendapatan keseluruhan yang dijana oleh syarikat daripada jualan barangan atau perkhidmatan. Tidak seperti keuntungan, tiada perbelanjaan ditolak.
Sejarah hasil bagi Lukas Biomedical Inc. dari 2026 hingga 2026
Hasil pada akhir setiap tahun
Tahun Hasil Ubah
Tidak cukup data untuk tarikh yang disediakan.
Hasil untuk syarikat atau pesaing serupa
Syarikat Hasil Perbezaan Hasil Negara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $2.23B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $15.70B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH